5.27
price up icon1.74%   0.09
after-market After Hours: 5.27
loading
Aldeyra Therapeutics Inc stock is traded at $5.27, with a volume of 353.19K. It is up +1.74% in the last 24 hours and down -1.31% over the past month. Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
See More
Previous Close:
$5.18
Open:
$5.12
24h Volume:
353.19K
Relative Volume:
0.66
Market Cap:
$313.15M
Revenue:
-
Net Income/Loss:
$-37.54M
P/E Ratio:
-5.9213
EPS:
-0.89
Net Cash Flow:
$-30.33M
1W Performance:
-2.77%
1M Performance:
-1.31%
6M Performance:
+26.68%
1Y Performance:
+138.46%
1-Day Range:
Value
$4.93
$5.275
1-Week Range:
Value
$4.93
$5.52
52-Week Range:
Value
$2.20
$6.5476

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Name
Name
Aldeyra Therapeutics Inc
Name
Phone
781-761-4904
Name
Address
131 HARTWELL AVENUE, LEXINGTON, MA
Name
Employee
10
Name
Twitter
@aldeyraaldx
Name
Next Earnings Date
2024-11-18
Name
Latest SEC Filings
Name
ALDX's Discussions on Twitter

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-03-24 Upgrade Oppenheimer Perform → Outperform
Apr-02-24 Resumed H.C. Wainwright Buy
Apr-27-22 Resumed H.C. Wainwright Buy
Feb-08-21 Initiated H.C. Wainwright Buy
Dec-16-20 Initiated Berenberg Buy
Oct-30-20 Initiated Jefferies Buy
Oct-16-20 Initiated BTIG Research Buy
Sep-22-20 Initiated Alliance Global Partners Buy
May-12-20 Initiated Oppenheimer Outperform
Dec-04-18 Initiated Citigroup Buy
Sep-26-18 Reiterated Cantor Fitzgerald Overweight
Sep-13-18 Initiated Janney Buy
Jan-26-18 Initiated Seaport Global Securities Buy
Sep-26-16 Initiated H.C. Wainwright Buy
Jul-01-16 Initiated Stifel Buy
Jul-01-15 Initiated Canaccord Genuity Buy
Mar-25-15 Initiated Chardan Capital Markets Buy
Mar-20-15 Reiterated H.C. Wainwright Buy
Nov-18-14 Initiated H.C. Wainwright Buy
Jun-19-14 Initiated Aegis Capital Buy
View All

Aldeyra Therapeutics Inc Stock (ALDX) Latest News

pulisher
Oct 31, 2024

Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting - StockTitan

Oct 31, 2024
pulisher
Oct 30, 2024

International Assets Investment Management LLC Buys 229,487 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

Short Interest in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Increases By 13.3% - MarketBeat

Oct 29, 2024
pulisher
Oct 28, 2024

(ALDX) Long Term Investment Analysis - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 21, 2024

Neuropathic Ocular Pain Pipeline Assessment 2024: Therapies, - openPR

Oct 21, 2024
pulisher
Oct 21, 2024

Neuropathic Ocular Pain Pipeline Assessment 2024: Therapies, Clinical Trials, Therapies, and Key Companies Involved by DelveInsight | Ocular Therapeutix, Aldeyra Therapeutics, Aciex Therapeutics - Barchart

Oct 21, 2024
pulisher
Oct 21, 2024

Allergic Conjunctivitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Bausch & Lomb Inc, Aldeyra Therapeutics, Vanda Pharma, OKYO - The Globe and Mail

Oct 21, 2024
pulisher
Oct 21, 2024

Allergic Conjunctivitis Pipeline 2024: Clinical Trials - openPR

Oct 21, 2024
pulisher
Oct 17, 2024

(ALDX) Investment Analysis - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 12, 2024

Dimensional Fund Advisors LP Sells 210,153 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat

Oct 12, 2024
pulisher
Oct 08, 2024

Nephrotic Syndrome Drugs Market Set for Rapid Expansion with - openPR

Oct 08, 2024
pulisher
Oct 07, 2024

(ALDX) Proactive Strategies - Stock Traders Daily

Oct 07, 2024
pulisher
Oct 05, 2024

American Century Companies Inc. Acquires 36,528 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Oct 05, 2024
pulisher
Oct 04, 2024

Renaissance Technologies LLC Sells 224,390 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Lexington biotech resubmits dry eye drug for FDA approval a year after rejection - The Business Journals

Oct 03, 2024
pulisher
Oct 03, 2024

Aldeyra Resubmits New Drug Application for Reproxalap for Dry Eye Disease - MD Magazine

Oct 03, 2024
pulisher
Oct 03, 2024

Aldeyra Therapeutics stock affirmed at Outperform on NDA submission By Investing.com - Investing.com Canada

Oct 03, 2024
pulisher
Oct 03, 2024

Aldeyra resubmits dry eye treatment NDA to FDA By Investing.com - Investing.com Australia

Oct 03, 2024
pulisher
Oct 03, 2024

Aldeyra Therapeutics Files Again for FDA OK of Dry-Eye Disease Treatment - MarketWatch

Oct 03, 2024
pulisher
Oct 03, 2024

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease - StockTitan

Oct 03, 2024
pulisher
Oct 02, 2024

Aldeyra Therapeutics extends loan agreement terms - Investing.com India

Oct 02, 2024
pulisher
Oct 02, 2024

Aldeyra Therapeutics extends loan agreement terms By Investing.com - Investing.com UK

Oct 02, 2024
pulisher
Oct 02, 2024

Aldeyra Therapeutics, Inc. Enters into the Fourth Amendment to Loan and Security Agreement - Marketscreener.com

Oct 02, 2024
pulisher
Oct 01, 2024

Aldeyra shares hold Outperform rating on pipeline progress By Investing.com - Investing.com Canada

Oct 01, 2024
pulisher
Oct 01, 2024

What was Aldeyra Therapeutics Inc (ALDX)’s performance in the last session? - US Post News

Oct 01, 2024
pulisher
Sep 30, 2024

Aldeyra Therapeutics Inc (ALDX) rating upgrades by Oppenheimer - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Market Watch Highlights: Aldeyra Therapeutics Inc (ALDX) Ends on an Upturn Note at 5.50 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Aldeyra Therapeutics Inc (ALDX) Performance and Fundamentals Dashboard tells a completely different story - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Buys 682,265 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat

Sep 30, 2024
pulisher
Sep 26, 2024

(ALDX) Trading Signals - Stock Traders Daily

Sep 26, 2024
pulisher
Sep 25, 2024

Market Highlights: Aldeyra Therapeutics Inc (ALDX) Ends on a High Note at 5.65 - The Dwinnex

Sep 25, 2024
pulisher
Sep 25, 2024

What technical indicators reveal about ALDX stock - US Post News

Sep 25, 2024
pulisher
Sep 24, 2024

Bank of New York Mellon Corp Has $648,000 Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Insider Sale Alert: Aldeyra Therapeutics Inc [ALDX] – Is it Time to sell? - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Get in on Aldeyra Therapeutics Inc’s (ALDX) buy-in window today! - SETE News

Sep 23, 2024
pulisher
Sep 21, 2024

Federated Hermes Inc. Takes Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Federated Hermes Inc. Invests $1.76 Million in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Sep 21, 2024
pulisher
Sep 19, 2024

Aldeyra To Make Second Bid For FDA Approval Of Dry Eye Disease Drug - RTTNews

Sep 19, 2024
pulisher
Sep 12, 2024

Los Angeles Capital Management LLC Decreases Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Sep 12, 2024
pulisher
Sep 11, 2024

Oppenheimer Upgrades Aldeyra Therapeutics Inc (ALDX) to an Outperform from a Perform - Knox Daily

Sep 11, 2024
pulisher
Sep 10, 2024

PFG Investments LLC Purchases Shares of 396,247 Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat

Sep 10, 2024
pulisher
Sep 06, 2024

ALDX Stock Sees Surge of Approximately 20.38% in Last Five Days - Knox Daily

Sep 06, 2024
pulisher
Sep 05, 2024

There is no doubt that Aldeyra Therapeutics Inc (ALDX) ticks all the boxes. - SETE News

Sep 05, 2024
pulisher
Sep 05, 2024

Metric Deep Dive: Understanding Aldeyra Therapeutics Inc (ALDX) Through its Ratios - The Dwinnex

Sep 05, 2024
pulisher
Sep 05, 2024

Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 05, 2024
pulisher
Sep 04, 2024

High Growth Tech Stocks To Watch In The United States - Simply Wall St

Sep 04, 2024
pulisher
Sep 04, 2024

Aldeyra Therapeutics Inc (ALDX) requires closer examination - US Post News

Sep 04, 2024
pulisher
Sep 03, 2024

Aldeyra Therapeutics appoints new financial officer - Investing.com India

Sep 03, 2024
pulisher
Sep 03, 2024

Aldeyra Therapeutics appoints new financial officer By Investing.com - Investing.com Canada

Sep 03, 2024
pulisher
Sep 03, 2024

Aldeyra Therapeutics Announces Executive Team Changes - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

Aldeyra Therapeutics Inc Inc. (ALDX) Price Performance: The Impact of Insider Trading and Institutional Holdings - The InvestChronicle

Sep 03, 2024

Aldeyra Therapeutics Inc Stock (ALDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):